Cargando…

Frequency of Kell and Rh alloantibodies in Iranian Thalassemia Patients in Khorasan Razavi Province, Iran

Background: Thalassemia is an inherited disease with anemia and hemolysis. Blood transfusion is a routine treatment for thalassemia patients; alloimmunization is one of the complications of blood transfusion, which is very serious for these patients, especially girls and young women. Materials and M...

Descripción completa

Detalles Bibliográficos
Autores principales: Mollahoseini Foomani, Farzad, Sadeghian, Mohammad Hadi, Bagheri, Saeede, Badiee, Zahra, Bazargani, Reihane, Aryanpour, Zahra, Hallajiayan, Saeid, Shams, Seyyede Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448921/
https://www.ncbi.nlm.nih.gov/pubmed/37638288
http://dx.doi.org/10.18502/ijhoscr.v17i1.11707
_version_ 1785094837504049152
author Mollahoseini Foomani, Farzad
Sadeghian, Mohammad Hadi
Bagheri, Saeede
Badiee, Zahra
Bazargani, Reihane
Aryanpour, Zahra
Hallajiayan, Saeid
Shams, Seyyede Fatemeh
author_facet Mollahoseini Foomani, Farzad
Sadeghian, Mohammad Hadi
Bagheri, Saeede
Badiee, Zahra
Bazargani, Reihane
Aryanpour, Zahra
Hallajiayan, Saeid
Shams, Seyyede Fatemeh
author_sort Mollahoseini Foomani, Farzad
collection PubMed
description Background: Thalassemia is an inherited disease with anemia and hemolysis. Blood transfusion is a routine treatment for thalassemia patients; alloimmunization is one of the complications of blood transfusion, which is very serious for these patients, especially girls and young women. Materials and Methods: In this cross-sectional study, 446 thalassemia patients were examined. Demographic information of patients was extracted and recorded. The phenotype of ABO, Rh, and Kell antigens (tube method) with antisera from IMMUNDIANOSTICA Company (Germany) and the frequency of alloantibodies were determined. Results: 55.8% of the studied individuals were male, and 44.2% were female. Mean age of the studied patients was 19.94±10.63. The alloantibodies were detected in 7.5% of cell-pack receivers. The most prevalent phenotype of the ABO system was the O blood group (37.4%), and the most abundant antigen of the Rh group was ‘e’, which was found in 99.8% of the studied population. The most common alloantibody detected was Anti K (38.2%); concerning kell phenotype, (K(_)k(+)) and (K(+)k(+)) were found in 99.3% and 0.7% of patients, respectively. The frequency of Anti-D, Anti-C, Anti-c, and Anti-E was 23.5%, 14.7%, 2.9%, and 14.7%, respectively. Conclusion: According to the results of this paper, finding the compatible packed cells in terms of Kell and Rh systems antigens in addition to the ABO blood group is recommended to decrease the rate of alloantibodies in thalassemia patients.
format Online
Article
Text
id pubmed-10448921
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center
record_format MEDLINE/PubMed
spelling pubmed-104489212023-08-25 Frequency of Kell and Rh alloantibodies in Iranian Thalassemia Patients in Khorasan Razavi Province, Iran Mollahoseini Foomani, Farzad Sadeghian, Mohammad Hadi Bagheri, Saeede Badiee, Zahra Bazargani, Reihane Aryanpour, Zahra Hallajiayan, Saeid Shams, Seyyede Fatemeh Int J Hematol Oncol Stem Cell Res Original Article Background: Thalassemia is an inherited disease with anemia and hemolysis. Blood transfusion is a routine treatment for thalassemia patients; alloimmunization is one of the complications of blood transfusion, which is very serious for these patients, especially girls and young women. Materials and Methods: In this cross-sectional study, 446 thalassemia patients were examined. Demographic information of patients was extracted and recorded. The phenotype of ABO, Rh, and Kell antigens (tube method) with antisera from IMMUNDIANOSTICA Company (Germany) and the frequency of alloantibodies were determined. Results: 55.8% of the studied individuals were male, and 44.2% were female. Mean age of the studied patients was 19.94±10.63. The alloantibodies were detected in 7.5% of cell-pack receivers. The most prevalent phenotype of the ABO system was the O blood group (37.4%), and the most abundant antigen of the Rh group was ‘e’, which was found in 99.8% of the studied population. The most common alloantibody detected was Anti K (38.2%); concerning kell phenotype, (K(_)k(+)) and (K(+)k(+)) were found in 99.3% and 0.7% of patients, respectively. The frequency of Anti-D, Anti-C, Anti-c, and Anti-E was 23.5%, 14.7%, 2.9%, and 14.7%, respectively. Conclusion: According to the results of this paper, finding the compatible packed cells in terms of Kell and Rh systems antigens in addition to the ABO blood group is recommended to decrease the rate of alloantibodies in thalassemia patients. Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2023-01-01 /pmc/articles/PMC10448921/ /pubmed/37638288 http://dx.doi.org/10.18502/ijhoscr.v17i1.11707 Text en Copyright © 2023 Tehran University of Medical Sciences. https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license (https://creativecommons.org/licenses/by-nc/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited.
spellingShingle Original Article
Mollahoseini Foomani, Farzad
Sadeghian, Mohammad Hadi
Bagheri, Saeede
Badiee, Zahra
Bazargani, Reihane
Aryanpour, Zahra
Hallajiayan, Saeid
Shams, Seyyede Fatemeh
Frequency of Kell and Rh alloantibodies in Iranian Thalassemia Patients in Khorasan Razavi Province, Iran
title Frequency of Kell and Rh alloantibodies in Iranian Thalassemia Patients in Khorasan Razavi Province, Iran
title_full Frequency of Kell and Rh alloantibodies in Iranian Thalassemia Patients in Khorasan Razavi Province, Iran
title_fullStr Frequency of Kell and Rh alloantibodies in Iranian Thalassemia Patients in Khorasan Razavi Province, Iran
title_full_unstemmed Frequency of Kell and Rh alloantibodies in Iranian Thalassemia Patients in Khorasan Razavi Province, Iran
title_short Frequency of Kell and Rh alloantibodies in Iranian Thalassemia Patients in Khorasan Razavi Province, Iran
title_sort frequency of kell and rh alloantibodies in iranian thalassemia patients in khorasan razavi province, iran
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448921/
https://www.ncbi.nlm.nih.gov/pubmed/37638288
http://dx.doi.org/10.18502/ijhoscr.v17i1.11707
work_keys_str_mv AT mollahoseinifoomanifarzad frequencyofkellandrhalloantibodiesiniranianthalassemiapatientsinkhorasanrazaviprovinceiran
AT sadeghianmohammadhadi frequencyofkellandrhalloantibodiesiniranianthalassemiapatientsinkhorasanrazaviprovinceiran
AT bagherisaeede frequencyofkellandrhalloantibodiesiniranianthalassemiapatientsinkhorasanrazaviprovinceiran
AT badieezahra frequencyofkellandrhalloantibodiesiniranianthalassemiapatientsinkhorasanrazaviprovinceiran
AT bazarganireihane frequencyofkellandrhalloantibodiesiniranianthalassemiapatientsinkhorasanrazaviprovinceiran
AT aryanpourzahra frequencyofkellandrhalloantibodiesiniranianthalassemiapatientsinkhorasanrazaviprovinceiran
AT hallajiayansaeid frequencyofkellandrhalloantibodiesiniranianthalassemiapatientsinkhorasanrazaviprovinceiran
AT shamsseyyedefatemeh frequencyofkellandrhalloantibodiesiniranianthalassemiapatientsinkhorasanrazaviprovinceiran